Cameron Brennan, MD

Memorial Sloan-Kettering Cancer Center

Identification of fusion kinases as potential therapeutic targets in malignant astrocytoma and oligodendroglioma including malignant glioma

Alan D'Andrea, MD

Dana-Farber Cancer Institute

Inhibitors of the fanconi anemia Pathway as Chemosensitizing Agents for 1,3-Bis(2-Chloroethyl)-1-Nitrosourea (BCNU) in the Treatment of Brain Tumors

Ingo Mellinghoff, MD

University of California Los Angeles

A Genome-Wide View of mTOR Dependence in GBM

Paul Mischel, MD

Univerisity of California Los Angeles

Development of a microPLC for molecular diagnosis of Glioblastoma

Jeremy Rich, MD

Duke University

Targeting DNA Damage Checkpoint Signaling in Glioma Radioresistance

Axel Schönthal, PhD

University of Southern California

Flouting COX-2: Applying the COX-2-Independent Anti-Tumor Efficacy of Celebrex to the Therapy of Glioblastoma

Angela van Tilborg, PhD

University of Amsterdam

Protein kinase target profiling and ex vivo target validation to identify efficacious inhibitors for malignant glioma

WK Alfred Yung, MD

University of Texas/MD Anderson Cancer Center

Evaluation of Small Molecule Inhibitors of the P13K/AKT Pathway